/term/is-fee-revenue-and-other-income/STU:6A3A Autolus Therapeutics (STU:6A3A) Fees and Other Income
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Autolus Therapeutics PLC (STU:6A3A) » Definitions » Fees and Other Income

Autolus Therapeutics (STU:6A3A) Fees and Other Income


View and export this data going back to 2018. Start your Free Trial

What is Autolus Therapeutics Fees and Other Income?

Fees and Other Income only applies to insurance companies.

Autolus Therapeutics (STU:6A3A) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Autolus Therapeutics PLC (STU:6A3A) » Definitions » Fees and Other Income
Comparable Companies
ZYME VERA ALPN ALLO TARS TBPH TYRA ELVN AVXL LYEL OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
AUTL:USA 6A3A:Germany
Address
191 Wood Lane, The MediaWorks, London, GBR, W12 7FP
Website
https://www.autolus.com
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.